Literature DB >> 1312900

The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B.

Y P Tsao1, P D'Arpa, L F Liu.   

Abstract

Cell cycle arrest in G2 phase is a common response to a variety of DNA-damaging agents. The coupling between DNA damage and G2 arrest was studied in synchronized HeLa cells using camptothecin, a highly specific inhibitor of topoisomerase I that damages DNA through the formation of reversible topoisomerase I-DNA cleavable complexes. Brief camptothecin treatment of early S-phase HeLa cells caused arrest at G2 phase and abolished the activation of p34cdc2 protein kinase. Both tyrosine dephosphorylation of p34cdc2 and cyclin B accumulation were altered. These cell cycle-dependent changes were not observed when DNA replication was inhibited by aphidicolin during the brief camptothecin treatment. Our results suggest that to produce G2 arrest, active DNA synthesis is required at the time of camptothecin treatment, as was previously shown for camptothecin-induced cytotoxicity. Furthermore, our results suggest that the interaction of the replication fork with DNA damage may ultimately trigger altered regulation of p34cdc2/cyclin B, leading to cell cycle arrest at the G2 phase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312900

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

Review 1.  Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?

Authors:  Fengzhi Li; Tao Jiang; Qingyong Li; Xiang Ling
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

2.  A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells.

Authors:  Ning Wu; Xi-Wei Wu; Keli Agama; Yves Pommier; Jun Du; Ding Li; Lian-Quan Gu; Zhi-Shu Huang; Lin-Kun An
Journal:  Biochemistry       Date:  2010-11-08       Impact factor: 3.162

Review 3.  Repair of topoisomerase I-mediated DNA damage.

Authors:  Yves Pommier; Juana M Barcelo; V Ashutosh Rao; Olivier Sordet; Andrew G Jobson; Laurent Thibaut; Ze-Hong Miao; Jennifer A Seiler; Hongliang Zhang; Christophe Marchand; Keli Agama; John L Nitiss; Christophe Redon
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

4.  p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.

Authors:  H Christian Reinhardt; Aaron S Aslanian; Jacqueline A Lees; Michael B Yaffe
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

5.  Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells.

Authors:  Yanchun Wang; Zhongguang Luo; Yongfu Pan; Weige Wang; Xiaoyan Zhou; Lak Shin Jeong; Yiwei Chu; Jie Liu; Lijun Jia
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

6.  Inhibitory effect of zinc on human prostatic carcinoma cell growth.

Authors:  J Y Liang; Y Y Liu; J Zou; R B Franklin; L C Costello; P Feng
Journal:  Prostate       Date:  1999-08-01       Impact factor: 4.104

7.  Tracking the cell cycle origins for escape from topotecan action by breast cancer cells.

Authors:  G P Feeney; R J Errington; M Wiltshire; N Marquez; S C Chappell; P J Smith
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

8.  Schedule-dependent cytotoxicity of 5-fluorouracil and irinotecan in a colon cancer cell line.

Authors:  Yasuhiro Inoue; Chikao Miki; Hideki Watanabe; Junichiro Hiro; Yuji Toiyama; Eiki Ojima; Hidenori Yanagi; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

Review 9.  Camptothecins: a review of their chemotherapeutic potential.

Authors:  Hulya Ulukan; Peter W Swaan
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  Role of Cdc6 in re-replication in cells expressing human papillomavirus E7 oncogene.

Authors:  Xueli Fan; Yunying Zhou; Jason J Chen
Journal:  Carcinogenesis       Date:  2016-05-06       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.